Inhibition of Orotidine 5-Monophosphate Decarboxylase and Its Therapeutic Potential

Title: Inhibition of Orotidine 5-Monophosphate Decarboxylase and Its Therapeutic Potential

Volume: 8 Issue: 3

Author(s): L. P. Kotra, M. E. Meza-Avina, L. Wei, M. G. Buhendwa, E. Poduch, A. M. Bello and E. F. Pai

Affiliation:

Keywords: Orotidine 5'-monophosphate decarboxylase, de novo nucleotide synthesis, pyrimidine nucleotides, drug design

Abstract: Orotidine 5-monophosphate decarboxylase (ODCase) is among the most proficient enzymes, and catalyzes the decarboxylation of OMP to UMP. An overview of ODCase and various proposals for its catalytic mechanism of decarboxylation are briefly presented here. A number of inhibitors of ODCase and new developments in the X-ray structures of ODCases from different species are discussed in the context of their therapeutic potential against cancer and infectious diseases. Latest discoveries in the inhibition of ODCase, for example using the novel C6 substitutions on the uridine, open new doors for drug discovery targeting parasitic diseases such as malaria.

Cite this article as:

Kotra P. L., Meza-Avina E. M., Wei L., Buhendwa G. M., Poduch E., Bello M. A. and Pai F. E., Inhibition of Orotidine 5-Monophosphate Decarboxylase and Its Therapeutic Potential, Mini-Reviews in Medicinal Chemistry 2008; 8 (3) . https://dx.doi.org/10.2174/138955708783744065